Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by E. Weisberg
A Novel Combination Therapy Approach for the Treatment of Acute Myeloid Leukemia: The Multi-Kinase Inhibitor Sorafenib and the HDM2 Inhibitor Nutlin-3
Haematologica
Hematology
Inhibition of Wild-Type P53-Expressing AML by the Novel Small Molecule HDM2 Inhibitor CGM097
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Clinical Experience With the BCL2-inhibitor Venetoclax in Combination Therapy for Relapsed and Refractory Acute Myeloid Leukemia and Related Myeloid Malignancies
American Journal of Hematology
Hematology
Effects of the Multi‐kinase Inhibitor Midostaurin in Combination With Chemotherapy in Models of Acute Myeloid Leukaemia
Journal of Cellular and Molecular Medicine
Molecular Medicine
Cell Biology
A Review of Efficacy and Safety of Checkpoint Inhibitor for the Treatment of Acute Myeloid Leukemia
Frontiers in Pharmacology
Pharmacology
Combination Treatment of an IDH1 Inhibitor With Chemotherapy in IDH1 Mutant Acute Myeloid Leukemia
Annals of Hematology
Medicine
Hematology
The Sorafenib Plus Nutlin-3 Combination Promotes Synergistic Cytotoxicity in Acute Myeloid Leukemic Cells Irrespectively of FLT3 and P53 Status
Haematologica
Hematology
Superior Activity of the Combination of Histone Deacetylase Inhibitor LAQ824 and the FLT-3 Kinase Inhibitor PKC412 Against Human Acute Myelogenous Leukemia Cells With Mutant FLT-3
Clinical Cancer Research
Cancer Research
Oncology
Managing Chronic Myeloid Leukemia Patients Intolerant to Tyrosine Kinase Inhibitor Therapy
Blood Cancer Journal
Oncology
Hematology
MDM2 Inhibitor, Nutlin 3a, Induces P53 Dependent Autophagy in Acute Leukemia by AMP Kinase Activation
PLoS ONE
Multidisciplinary
Frequent Loss of RAF Kinase Inhibitor Protein Expression in Acute Myeloid Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
